Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 304,995 | 395,630 | 346,706 | 307,024 | 315,546 |
| Cost of Goods | 40,319 | 44,731 | 43,208 | 39,519 | 44,002 |
| Gross Profit | 264,676 | 350,899 | 303,498 | 267,505 | 271,544 |
| Operating Expenses | 230,679 | 238,684 | 241,546 | 238,347 | 223,907 |
| Operating Income | 34,316 | 112,946 | 62,160 | 29,677 | 47,639 |
| Other Income | 9,486 | 6,753 | 9,442 | 11,991 | 7,877 |
| Pre-tax Income | 43,802 | 119,699 | 71,602 | 41,668 | 55,516 |
| Income Tax | 14,588 | 24,245 | 17,921 | -7,986 | 8,974 |
| Net Income Continuous | 29,214 | 95,454 | 53,681 | 49,654 | 46,542 |
| Minority Interests | 612 | 539 | 354 | 322 | 471 |
| Net Income | $28,602 | $94,915 | $53,327 | $49,332 | $46,071 |
| EPS Basic Total Ops | 0.30 | 1.00 | 0.56 | 0.52 | 0.48 |
| EPS Basic Continuous Ops | 0.31 | 1.00 | 0.56 | 0.52 | 0.49 |
| EPS Diluted Total Ops | 0.30 | 0.99 | 0.55 | 0.50 | 0.48 |
| EPS Diluted Continuous Ops | 0.31 | 1.00 | 0.56 | 0.50 | 0.48 |
| EPS Diluted Before Non-Recurring Items | 0.43 | 1.12 | 0.73 | 0.73 | 0.53 |
| EBITDA(a) | $59,388 | $139,792 | $88,973 | $54,252 | $72,037 |